Testing effectiveness (Phase 2)Ended earlyNCT00126191
What this trial is testing
Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
Who this might be right for
Burkitt LymphomaNon-Hodgkins LymphomaAtypical Burkitt Lymphoma
Dana-Farber Cancer Institute 10